Literature DB >> 8641706

Allelic loss of the short arm of chromosome 4 in neuroblastoma suggests a novel tumour suppressor gene locus.

H Caron1, P van Sluis, R Buschman, R Pereira do Tanque, P Maes, L Beks, J de Kraker, P A Voûte, G Vergnaud, A Westerveld, R Slater, R Versteeg.   

Abstract

Neuroblastoma is a childhood neural crest tumour, genetically characterized by frequent deletions of the short arm of chromosome 1 and amplification of N-myc. Here we report the first evidence for a neuroblastoma tumour suppressor locus on 4pter. Cytogenetically we demonstrated rearrangements of 4p in 7 out of 26 evaluable tumours (27%). Subsequent analysis of loss of heterozygosity (LOH) by Southern blotting revealed allelic loss of 4p in 16/82 (19.5%) informative neuroblastomas. Taken together cytogenetic and Southern blot analyses showed loss of 4p in 20/86 neuroblastomas analysed (23%). The common deleted region was bordered by the probe D4S123 and encompassed the distal 34 cM of 4p. We found no evidence for genomic imprinting of the 4p locus as the 4p alleles lost in the tumours were of random maternal and paternal origin. LOH4p was found at all disease stages and in every age group. Furthermore LOH4p was present both in cases with and without LOH1p and amplification of N-myc.

Entities:  

Mesh:

Year:  1996        PMID: 8641706     DOI: 10.1007/bf02346199

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  14 in total

1.  Paternal origin of the chromosomal deletion resulting in Wolf-Hirschhorn syndrome.

Authors:  O W Quarrell; R G Snell; M A Curtis; S H Roberts; P S Harper; D J Shaw
Journal:  J Med Genet       Date:  1991-04       Impact factor: 6.318

2.  Loss of heterozygosity suggests tumor suppressor gene responsible for primary hepatocellular carcinoma.

Authors:  K H Buetow; J C Murray; J L Israel; W T London; M Smith; M Kew; V Blanquet; C Brechot; A Redeker; S Govindarajah
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

3.  Loss of heterozygosity for alleles on chromosomes 11q and 14q in neuroblastoma.

Authors:  E S Srivatsan; V Murali; R C Seeger
Journal:  Prog Clin Biol Res       Date:  1991

4.  Loss of heterozygosity for chromosomes 1 or 14 defines subsets of advanced neuroblastomas.

Authors:  C T Fong; P S White; K Peterson; C Sapienza; W K Cavenee; S E Kern; B Vogelstein; A B Cantor; A T Look; G M Brodeur
Journal:  Cancer Res       Date:  1992-04-01       Impact factor: 12.701

5.  Frequent loss of heterozygosity on chromosome 14q in neuroblastoma.

Authors:  T Suzuki; J Yokota; H Mugishima; I Okabe; M Ookuni; T Sugimura; M Terada
Journal:  Cancer Res       Date:  1989-03-01       Impact factor: 12.701

6.  Allelic loss of chromosome 1 and additional chromosome 17 material are both unfavourable prognostic markers in neuroblastoma.

Authors:  H Caron
Journal:  Med Pediatr Oncol       Date:  1995-04

7.  Allelic loss of chromosome 1p36 in neuroblastoma is of preferential maternal origin and correlates with N-myc amplification.

Authors:  H Caron; P van Sluis; M van Hoeve; J de Kraker; J Bras; R Slater; M Mannens; P A Voûte; A Westerveld; R Versteeg
Journal:  Nat Genet       Date:  1993-06       Impact factor: 38.330

8.  Suppression of tumorigenicity in human teratocarcinoma cell line PA-1 by introduction of chromosome 4.

Authors:  I J McGowan-Jordan; M D Speevak; D Blakey; M Chevrette
Journal:  Cancer Res       Date:  1994-05-15       Impact factor: 12.701

9.  Regression and progression in neuroblastoma. Does genetics predict tumour behaviour?

Authors:  P F Ambros; I M Ambros; S Strehl; S Bauer; A Luegmayr; H Kovar; R Ladenstein; F M Fink; E Horcher; G Printz
Journal:  Eur J Cancer       Date:  1995       Impact factor: 9.162

10.  Evidence for two tumour suppressor loci on chromosomal bands 1p35-36 involved in neuroblastoma: one probably imprinted, another associated with N-myc amplification.

Authors:  H Caron; M Peter; P van Sluis; F Speleman; J de Kraker; G Laureys; J Michon; L Brugières; P A Voûte; A Westerveld
Journal:  Hum Mol Genet       Date:  1995-04       Impact factor: 6.150

View more
  14 in total

1.  RNF4 is a growth inhibitor expressed in germ cells but not in human testicular tumors.

Authors:  R Pero; F Lembo; D Di Vizio; A Boccia; P Chieffi; M Fedele; G M Pierantoni; P Rossi; R Iuliano; M Santoro; G Viglietto; C B Bruni; A Fusco; L Chiariotti
Journal:  Am J Pathol       Date:  2001-10       Impact factor: 4.307

2.  Are there tumor suppressor genes on chromosome 4p in sporadic colorectal carcinoma?

Authors:  Hai-Tao Zheng; Li-Xin Jiang; Zhong-Chuan Lv; Da-Peng Li; Chong-Zhi Zhou; Jian-Jun Gao; Lin He; Zhi-Hai Peng
Journal:  World J Gastroenterol       Date:  2008-01-07       Impact factor: 5.742

Review 3.  Neuroblastoma tumour genetics: clinical and biological aspects.

Authors:  N Bown
Journal:  J Clin Pathol       Date:  2001-12       Impact factor: 3.411

Review 4.  The connections between neural crest development and neuroblastoma.

Authors:  Manrong Jiang; Jennifer Stanke; Jill M Lahti
Journal:  Curr Top Dev Biol       Date:  2011       Impact factor: 4.897

5.  Region-specific detection of neuroblastoma loss of heterozygosity at multiple loci simultaneously using a SNP-based tag-array platform.

Authors:  John M Maris; George Hii; Craig A Gelfand; Shobha Varde; Peter S White; Eric Rappaport; Saul Surrey; Paolo Fortina
Journal:  Genome Res       Date:  2005-08       Impact factor: 9.043

6.  Comparison of different techniques for the detection of genetic risk-identifying chromosomal gains and losses in neuroblastoma.

Authors:  Eva Villamón; Marta Piqueras; Carlos Mackintosh; Javier Alonso; Enrique de Alava; Samuel Navarro; Rosa Noguera
Journal:  Virchows Arch       Date:  2008-06-24       Impact factor: 4.064

7.  Bioinformatics analysis of recurrent deletion regions in neuroblastoma.

Authors:  Hasan Onur Caglar
Journal:  Med Oncol       Date:  2022-01-20       Impact factor: 3.064

Review 8.  Biomarkers in Neuroblastoma: An Insight into Their Potential Diagnostic and Prognostic Utilities.

Authors:  Fatima Shawraba; Hussein Hammoud; Yara Mrad; Zahraa Saker; Youssef Fares; Hayat Harati; Hisham F Bahmad; Sanaa Nabha
Journal:  Curr Treat Options Oncol       Date:  2021-09-27

9.  International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee.

Authors:  P F Ambros; I M Ambros; G M Brodeur; M Haber; J Khan; A Nakagawara; G Schleiermacher; F Speleman; R Spitz; W B London; S L Cohn; A D J Pearson; J M Maris
Journal:  Br J Cancer       Date:  2009-05-05       Impact factor: 7.640

10.  Loss of heterozygosity of 3p markers in neuroblastoma tumours implicate a tumour-suppressor locus distal to the FHIT gene.

Authors:  K Ejeskär; H Aburatani; J Abrahamsson; P Kogner; T Martinsson
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.